All stocks / BIOE
Bio Essence Corp BIOE
Bio Essence (BIOE): shares outstanding up 42% in a year, 1 insider sale or sale notice in 90 days and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- BIO ESSENCE CORP
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- Nov 13
- Website
- www.bioessencecorp.com
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Revenue
- $1,897,566
- Net income
- $896,197
It earned more than it spent
SteadyAfter all costs, the company kept $896,197 as profit in the year.
- Total assets
- $422,474
- Total liabilities
- $2,495,367
It owes more than it owns
Under strainEverything the company owns adds up to $422,474. Its debts and unpaid bills add up to $2.5 million. That is about $5.91 owed for every $1 owned.
What this adds up to
1 of 2 checks show strain. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Shares outstanding rose from 38,009,000 (2025-11-15) to 53,809,000 (2026-11-12), up 42%.
Rule: Shares outstanding up 20% or more in 12 months. Source record
Estimated float about 40,413,000 shares as of 2026-11-12: 53,809,000 outstanding minus 13,396,000 held by 1 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
YIN YAN filed notice of a proposed sale of 550,000 shares (Form 144, 2026-10-13).
Rule: Form 4 or Form 144 sale in the last 90 days. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
| 2026-11-13 | 10-Q | QUARTERLY REPORT |
| 2026-10-23 | 8-K | CURRENT REPORT |
| 2026-10-21 | PRE 14C | PRELIMINARY INFORMATION STATEMENT |
| 2026-10-14 | 4/A | |
| 2026-10-13 | 144 | |
| 2026-08-14 | 10-Q | QUARTERLY REPORT |
| 2026-05-19 | 8-K/A | AMENDMENT NO. 1 TO FORM 8-K |
| 2026-05-15 | 10-Q | QUARTERLY REPORT |
| 2026-04-24 | 8-K | CURRENT REPORT |
| 2026-03-27 | 10-K | ANNUAL REPORT |
| 2026-01-05 | QUALIF |
Common questions about BIOE
Does BIOE file reports with the SEC?
Yes. Bio Essence files with the SEC under company number 0001723059. The most recent filing we hold is a 10-Q dated 2026-11-13.
Source recordHow many BIOE shares are outstanding?
53,809,000 shares as of 2026-11-12, as reported to the SEC. That is up 42% from 38,009,000 on 2025-11-15.
Source recordHas BIOE filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Have BIOE insiders sold shares recently?
1 insider sale or sale notice was filed in the last 90 days. Most recent: YIN YAN filed notice of a proposed sale of 550,000 shares (Form 144, 2026-10-13).
Source recordWho runs Bio Essence?
Officers named in its insider filings: Yin Yan (Chief Executive Officer).
Source recordIs Bio Essence making money?
After all costs, the company kept $896,197 as profit in the year. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record